Catalyst Wire Dossier Catalyst Wire Dossier

AD-230

· Addpharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-230, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults [Phase 1]

See pricing